Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yu-Qi-Dai is a Traditional Chinese Medicine (TCM) herbal product developed by Jiangxi TongTianLe Technology Co., Ltd., specifically designed for the treatment of neonatal jaundice (hyperbilirubinemia). The product is typically formulated as a medicinal bag used for external applications, such as medicinal baths or topical compresses. Its therapeutic approach is rooted in TCM principles of clearing heat, resolving dampness, and promoting gallbladder function (choleretic effect) to facilitate the breakdown and excretion of excess bilirubin. Common active herbal components include *Artemisia capillaris*, *Gardenia jasminoides*, and *Rheum palmatum*. Clinical use often involves Yu-Qi-Dai as an adjunct to conventional blue-light phototherapy to enhance the rate of bilirubin reduction and shorten the duration of treatment in newborns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yu-Qi-Dai.